IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v30y2010i2p217-223.html
   My bibliography  Save this article

Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing

Author

Listed:
  • A. David Paltiel

    (School of Medicine/School of Management, Yale University, New Haven, Connecticut, david.paltiel@yale.edu)

  • Harold A. Pollack

    (School of Social Service Administration/Center for Health Administration Studies, University of Chicago, Chicago, Illinois)

Abstract

The Food and Drug Administration (FDA) is considering approval of an over-the-counter, rapid HIV test for home use. To support its decision, the FDA seeks evidence of the test’s performance. It has asked the manufacturer to conduct field studies of the test’s sensitivity and specificity when employed by untrained users. In this article, the authors argue that additional information should be sought to evaluate the prevalence of undetected HIV in the end-user population. The analytic framework produces the elementary but counterintuitive finding that the performance of the home HIV test— measured in terms of its ability to correctly detect the presence and absence of HIV infection among the people who purchase it—depends critically on the manufacturer’s retail price. This finding has profound implications for the FDA’s approval process.

Suggested Citation

  • A. David Paltiel & Harold A. Pollack, 2010. "Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing," Medical Decision Making, , vol. 30(2), pages 217-223, March.
    • Handle: RePEc:sae:medema:v:30:y:2010:i:2:p:217-223
    DOI: 10.1177/0272989X09334420
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X09334420
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X09334420?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Holmberg, S.D., 1996. "The estimated prevalence and incidence of HIV in 96 large US metropolitan areas," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 642-654.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wilson, Amy R. & Kahn, James G., 2003. "Preventing HIV in injection drug users: exploring the tradeoffs between interventions," Socio-Economic Planning Sciences, Elsevier, vol. 37(4), pages 269-288, December.
    2. Steven D. Pinkerton & Eric G. Benotsch & John Mikytuck, 2007. "When Do Simpler Sexual Behavior Data Collection Techniques Suffice?," Evaluation Review, , vol. 31(4), pages 401-412, August.
    3. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2004. "A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention," Medical Decision Making, , vol. 24(6), pages 634-653, November.
    4. Georgiy Bobashev & Sarah Mars & Nicholas Murphy & Clinton Dreisbach & William Zule & Daniel Ciccarone, 2019. "Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-17, December.
    5. Lessner, Lawrence, 2008. "HIV prevalence for New York State using Newborn Seroprevalence and AIDS Surveillance Data," Socio-Economic Planning Sciences, Elsevier, vol. 42(4), pages 286-299, December.
    6. Schilling, Robert F. & Fontdevila, Jorge & Fernando, Daniel & El-Bassel, Nabila & Monterroso, Edgar, 2004. "Proximity to needle exchange programs and HIV-related risk behavior among injection drug users in Harlem," Evaluation and Program Planning, Elsevier, vol. 27(1), pages 25-33, February.
    7. Iguchi, Martin Y. & Bux, Donald A. & Kushner, Harvey & Lidz, Victor, 2001. "Correlates of HIV risk among female sex partners of injecting drug users in a high-seroprevalence area," Evaluation and Program Planning, Elsevier, vol. 24(2), pages 175-185, May.
    8. Amy Lansky & Teresa Finlayson & Christopher Johnson & Deborah Holtzman & Cyprian Wejnert & Andrew Mitsch & Deborah Gust & Robert Chen & Yuko Mizuno & Nicole Crepaz, 2014. "Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-9, May.
    9. Wilson, Amy R. & Kahn, James G. & Oren, Shmuel S., 2005. "Targeting interventions to high-risk populations: Benefits and costs," Socio-Economic Planning Sciences, Elsevier, vol. 39(4), pages 335-349, December.
    10. Barton H. Hamilton & Andrés Hincapié & Robert A. Miller & Nicholas W. Papageorge, 2021. "Innovation And Diffusion Of Medical Treatment," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 62(3), pages 953-1009, August.
    11. Steven D. Pinkerton & David R. Holtgrave & Laura C. Leviton & David A. Wagstaff & Paul R. Abramson, 1998. "Model-Based Evaluation of Hiv Prevention Interventions," Evaluation Review, , vol. 22(2), pages 155-174, April.
    12. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2001. "Probabilistic Cost-Effectiveness Analysis of HIV Prevention," Evaluation Review, , vol. 25(4), pages 474-502, August.
    13. Schilling, Robert F. & Fernando, Daniel & Fontdevila, Jorge & El-Bassel, Nabila, 2000. "HIV risk reduction among injection drug users: explaining the lack of anticipated outcomes in a community-level controlled comparison study," Evaluation and Program Planning, Elsevier, vol. 23(3), pages 301-313, August.
    14. Jonathan P. Caulkins & Edward H. Kaplan & Peter Lurie & Thomas O'Connor & Sung-Ho Ahn, 1998. "Can Difficult-to-Reuse Syringes Reduce the Spread of HIV Among Injection Drug Users?," Interfaces, INFORMS, vol. 28(3), pages 23-33, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:30:y:2010:i:2:p:217-223. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.